ArticleReproductive sciences (Thousand Oaks, Calif.)2025
Vitamin D Deficiency and VDR Gene Variants in Polycystic Ovary Syndrome: A Case-Control Study.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and influencing factors of vitamin D deficiency in women with polycystic ovary syndrome: a systematic review and meta-analysis.Frontiers in nutrition · 2026Pooled it
- Synergistic modulation of insulin resistance and ovarian oxidative stress by alpha-lipoic acid and vitamin D in an experimental rat model of polycystic ovary syndrome.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder in reproductive-aged women and adolescents. Vitamin D deficiency (VDD) and genetic variations in the vitamin D receptor (VDR) pronouncedly influence its manifestations. The interplay between VDD and VDR polymorphisms has an umbrella effect on the endocrine and metabolic milieu of PCOS, underscoring the importance of vitamin D (VD) in its management. This study tried to find out the association between VDD and single-nucleotide polymorphisms (SNPs) in the VDR gene in the differential pathophysiological manifestations of PCOS in the ethnic population of West Bengal, India. The case-control study was conducted involving 170 PCOS women (ages 17-36 years) and 150 of their gender, and age and ethnicity-matched healthy controls. VDD was assessed along with the association of VDR polymorphisms [BsmI (rs1544410) and FokI (rs2228570)] with the nutritional and biochemical indices. Bioelectrical impedance (anthropometric indices), structured questionnaires (sociodemographic characteristics, solar-UVB exposure and nutritional status), haematological estimation (VD and other necessary parameters) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP, VDR-SNPs) were employed in this study. In the PCOS population, the BsmI-VDR-based VD cutoff level was 19.17 ng/ml [asymptotic sig.: 0.000, with area under the curve (AUC): 0.894, sensitivity: 0.950, and specificity: 0.657] and the FokI-VDR-based VD cutoff level was 17.67 ng/ml [asymptotic sig.: 0.000, with AUC: 0.947, sensitivity: 0.875, and specificity: 0.732] derived by receiver operating characteristic (ROC) curve analysis. VDR-SNPs were further stratified by performing Sanger sequencing. Significant correlations were found between VDR variants and hyperandrogenism (HA), insulin resistance (IR), inflammatory markers, and obesity indices of PCOS patients. Mutant (BsmI-bb/Bb and FokI-ff/Ff) VDR genotypes were found to be influential upon the metabolic and cutaneous features of PCOS patients, suggesting a genetic basis for VD-related disturbances in PCOS. This study accentuates the need for personalised therapeutic strategies, particularly VD supplementation, based on genetic profiles to manage the severity and prevalence of PCOS and its associated metabolic deregulations.
Indexed as
Identifiers
41126011What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.